Guidant rapid exchange catheter unit sales up 50% worldwide in second quarter, Dollens reports.
This article was originally published in The Gray Sheet
Executive Summary
GUIDANT RAPID EXCHANGE CATHETER UNIT SALES UP 50% WORLDWIDE for the second quarter ended June 30, President and CEO Ron Dollens said Sept. 4 at a Jeffries & Company medical device conference in New York City. Driven by overseas sales of the company's Multi-Link coronary stent, which is deployed with the firm's rapid-exchange and over-the-wire balloon catheters, Dollens said that "rapid exchange has already become 44% of our dilatation catheter business."
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.